摘要
目的了解临床几种方案治疗细菌性上呼吸道感染的成本-效果,以利安全、合理、经济用药。方法将665例细菌性上呼吸道感染患者按使用抗生素治疗方案随机分成8组,按照药物经济学的成本-效果评价方法进行分析。结果 8组治疗成本分别为447.02元,488.18元,1 044.12元,153.02元,1 818.39元,1 323.14元,1 958.18元,498.54元;有效率分别为90.48%,91.46%,91.67%,92.77%,91.46%,89.16%,89.29%,90.36%(P>0.05);成本-效果比分别为4.94,5.34,11.39,1.65,19.88,14.84,21.93,5.52。其他各组相对于第4组增量成本-效果比分别为-109.13,-217.47,-688.57,-1 080.58,-275.51,-440.91,-121.86。结论治疗方案中,第4组注射用头孢曲松钠成本-效果较好。
Objective To understand the cost-effectiveness of several schemes in treating bacterial upper respiratory tract infection in our hospital for safe, rational and economic medication. Methods Six hundred and sixty- five cases of bacterial upper respiratolT tract infection were randomly divided into 8 groups according to the antibiotic treatment schemes and analyzed by the pharmacoeeonomic cost - effectiveness method. Results The treatment costs in 8 groups were 447.02,488.18, 1 044. 12, 153.02, 1 818.39, 1 323.14, 1 958. 18,498.54 Yuan, respectively. The effective rates were 90. 48% , 91.46% , 91.67% , 92.77% , 91.46% , 89. 16% , 89.29% and 90. 36%, respectively （ P 〉 0.05）. The cost - effectiveness ratios were 4.94, 5.34, 11.39, 1.65, 19.88, 14.84, 21.93 and 5.52 respectively. The incremental cost- effectiveness ratios of other groups relative to the fourth group were -109. 13, -217.47, -688.57, - 1080. 58, -275.51, -440. 91 and - 121.86. Conclusion Among various treatment sehemes, the fourth group of Ceftriaxone Sodium for Injection is better.
出处
《中国药业》
CAS
2012年第5期50-51,共2页
China Pharmaceuticals
关键词
子宫内膜癌
放射疗法
外科手术
bacterial upper respiratory tract infection
medication scheme
cost- effectiveness analysis
